Investment Summary

TA Associates Invests In Biocomposites

On June 5, 2017, private equity firm TA Associates invested in life science company Biocomposites

Investment Highlights
  • This is TA Associates’ 9th transaction in the Life Science sector.
  • This is TA Associates’ 207th transaction in the United States.
  • This is TA Associates’ 4th transaction in North Carolina.

Investment Summary
Date 2017-06-05
Target Biocomposites
Sector Life Science
Investor(s) TA Associates
Deal Type Growth Capital

Target

Biocomposites

Wilmington, North Carolina, United States
Biocomposites is a manufacturer and marketer of calcium compound biologics. Biocomposites is singularly focused on the development of innovative calcium compounds for surgical use. Their bone graft matrices can be used in the presence of infection for regenerating bone and managing dead space in a range of orthopedic procedures. Biocomposites sells directly to hospitals and through independent distributors, with the United States representing its largest market. Biocomposites was founded in 1997 and is based in Wilmington, North Carolina.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

TA Associates

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1968
PE ASSETS 65.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TA Associates is a private equity firm that targets investments in middle-market and large companies around the world. TA will consider control or minority investments in profitable companies and looks to commit between $70 and $500 million per transaction. TA proactively reaches out to companies directly in sourcing potential investment opportunities. Prospective businesses are generally valued between $100 million and $3 billion. Areas of interest include technology, software, communications, financial services, healthcare, business services, semiconductors/electronics, and consumer products/services. In addition to investing equity capital, TA also makes subordinated debt investments. TA's geographic preference is North America, Asia/Pacific, and Europe. TA Associates was formed in 1968 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 264 of 364
Sector (Life Science) 9 of 11
Type (Growth Capital) 100 of 133
State (North Carolina) 4 of 6
Country (United States) 207 of 263
Year (2017) 14 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-23 MRI Software

Solon, Ohio, United States

MRI Software is a provider of real estate software applications and hosted solutions. MRI’s comprehensive and flexible technology platform coupled with an open and connected ecosystem meets the unique needs of real estate businesses from property-level management and accounting to investment modeling and analytics for the global commercial and residential markets. MRI develops lasting client relationships based on nearly five decades of expertise and insight. MRI Software was established in 1971 and is based in Solon, Ohio.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-07 Riskonnect

Kennesaw, Georgia, United States

Riskonnect is a provider of integrated risk management software. The Company develops and markets a suite of software solutions on a cloud computing model, helping clients elevate their risk management programs, safety solutions, and programs for the management of risks across the enterprise. It provides the risk management industry with the configurable solutions needed to reduce losses, control risk, and affect shareholder value. Riskonnect was founded in 2007 and is based in Kennesaw, Georgia.

Buy -
Mergr

Product

Company

Legal